Lu Y, Chen FY, Cai L, Huang CX, Shen XF, Cai LQ, Li XT, Fu YY, Wei J. Early warning prevention and control strategies to reduce perioperative venous thromboembolism in patients with gastrointestinal cancer. World J Clin Cases 2022; 10(10): 3035-3046 [PMID: 35647130 DOI: 10.12998/wjcc.v10.i10.3035]
Corresponding Author of This Article
Xue-Fang Shen, MBBS, Doctor, The Fifth Ward of Surgery, Kunshan Hospital of Traditional Chinese Medicine, No. 189 Chaoyang Road, Kunshan 215300, Jiangsu Province, China. 13913262392@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 6, 2022; 10(10): 3035-3046 Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3035
Table 1 Characteristics of the patients in two groups
Item
Control (n = 128)
Early warning (n = 136)
P value
Sex, n (%)
Male
72 (56.3)
69 (50.7)
0.369
Female
56 (43.8)
67 (49.3)
Age (years), mean ± SD
65.9 ± 11.3
63.4 ± 12.7
0.096
BMI (kg/m2), mean ± SD
21.6 ± 3.3
22.3 ± 4.2
0.108
Education, n (%)
0.263
Junior middle school and below
36 (28.1)
41 (30.2)
Senior high school and technical secondary school
59 (40.1)
50 (36.8)
Junior college and undergraduate and above
33 (25.8)
45 (33.1)
Marital status, n (%)
0.736
Living with a spouse
86 (67.2)
94 (66.9)
Unmarried, widowed or divorced
42 (32.8)
42 (30.9)
Hypertension, n (%)
23 (17.9)
19 (14.0)
0.375
Diabetes, n (%)
18 (14.1)
24 (17.6)
0.402
Hyperlipemia, n (%)
15 (11.7)
18 (13.2)
0.710
Preoperative VTE risk classification, n (%)
0.488
Moderate risk
52 (40.6)
61 (44.9)
High risk
76 (59.4)
75 (55.2)
TNM, n (%)
0.928
I
34 (26.6)
39 (28.7)
II
51 (39.9)
53 (39.0)
III
43 (33.6)
44 (32.4)
Surgical method, n (%)
0.524
Radical resection of gastric cancer
68 (53.1)
70 (51.5)
Radical resection of rectal cancer
42 (32.8)
40 (29.4)
Radical resection of colon cancer
18 (14.1)
26 (19.12)
Operation time (min), mean ± SD
118.5 ± 45.7
121.8 ± 51.9
0.247
Intraoperative blood loss (mL), mean ± SD
85.3 ± 21.6
89.7 ± 23.6
0.076
Length of hospital stay (day), mean ± SD
15.27 ± 2.68
14.69 ± 2.35
0.062
Table 2 Comparison of deep vein thrombosis occurrence rate, venous thromboembolism risk assessment rate by nurses, and implementation rate of VTE preventive measures between the two groups
Control (n = 128)
Early warning (n = 136)
P value
Occurrence of DVT, n (%))
18 (14.1)
9 (6.6)
0.046
Correct rates of VTE risk assessment of nurse evaluation, n (%)
84 (65.6)
118 (86.8)
< 0.001
Standard implementation rate of VTE preventive measures of patients, n (%)
74 (57.8)
109 (80.2)
< 0.001
Table 3 Comparison of coagulation indicators between two groups at different points in time
Control (n = 128)
Early warning (n = 136)
P value
d-dimer (µg/mL), mean ± SD
Before
0.46 ± 0.20
0.44 ± 0.24
0.473
1 d
1.86 ± 0.96
2.04 ± 1.27
0.197
3 d
3.27 ± 1.85
2.68 ± 1.74
0.008
7 d
2.75 ± 1.82
1.52 ± 1.03
0.000
Prothrombin time (s), mean ± SD
Before
11.3 ± 1.4
11.1 ± 1.0
0.061
1 d
11.5 ± 1.1
11.3 ± 1.2
0.359
3 d
11.7 ± 1.0
11.5 ± 0.9
0.057
7 d
11.2 ± 1.2
11.3 ± 1.0
0.648
Fibrinogen degradation product, mean ± SD
Before
2.54 ± 1.52
2.67 ± 1.36
0.464
1 d
7.26 ± 3.21
6.82 ± 3.29
0.273
3 d
7.69 ± 2.27
5.62 ± 2.11
0.000
7 d
8.16 ± 4.26
4.38 ± 3.04
0.000
Activated partial thromboplastin time (s), mean ± SD
Before
33.1 ± 6.4
32.2 ± 5.7
0.242
1 d
35.6 ± 7.3
35.7 ± 6.6
0.925
3 d
34.6 ± 6.6
32.8 ± 7.3
0.523
7 d
62.3 ± 6.3
32.3 ± 6.6
0.247
Table 4 Univariate and Multivariate logistic regression analysis of the occurrence of postoperative deep vein thrombosis of patients with gastrointestinal cancer
DVT Group (n = 27)
Non-DVT Group (n = 237)
Univariate
Multivariate
OR
95%CI
P value
OR
95%CI
P value
Age
70.81 ± 7.95
60.17 ± 8.36
1.03
1.04-1.35
0.026
1.083
1.070-3.265
0.032
Gender
Male
16 (59.26)
125 (52.74)
1
Female
11 (40.74)
112 (47.26)
1.30
0. 58-2.93
0.52
BMI
22.56 ± 1.92
21.83 ± 2.51
1.09
0.96-1.23
0.145
Education background
Junior secondary and below
5 (18.52)
72 (30.38)
1
Above junior secondary
22 (81.48)
165 (69.62)
0.52
0.19-1.43
0.371
Marital status
Having a spouse
17 (62.96)
163 (68.78)
1
Unmarried, widowed, or divorced
10 (37.04)
74 (31.22)
0.77
0.33-1.76
0.539
Hypertension, no
17 (62.96)
205 (84.50)
3.77
1.58-8.95
0.002
Diabetes, no
22 (81.48)
200 (84.39)
1.23
0.43-3.45
0.78
Hyperlipidemia, yes
8 (29.63)
25 (10.55)
3.57
1.41-8.99
0.005
1.127
1.139-2.564
0.042
TNM
I, II
6 (22.22)
67 (28.27)
1
III
12 (44.45)
75 (31.65)
0.56
0.25-1.26
0.18
Surgery method
Radical gastrectomy
13 (48.15)
125 (52.74)
1
Radical resection of colorectal cancer
9 (33.33)
73 (30.80)
0.832
0.37-1.81
0.651
Preoperative VTE risk grade
Medium-risk
6 (22.22)
107 (45.15)
1
High risk
21 (77.78)
130 (54.85)
1.12
0.13-0.89
0.023
2.131
1.085-5.178
0.001
Time of operation (min)
128.4 ± 29.47
112.2 ± 35.76
1.07
1.13-1.37
0.024
2.268
2.005-5.546
0.026
Intraoperative bleeding volume (mL)
91.46 ± 17.38
85.25 ± 20.26
1.06
0.48-1.26
0.127
Adoption of early warning prevention, no
18 (66.67)
110 (46.41)
1.28
0.18-1.0
0.046
3.747
1.523-6.956
0.017
Table 5 Comparison of venous thromboembolism knowledge in nurses before and after implementation
Before implementation (n = 86)
After implementation (n = 86)
P value
VTE basic knowledge, mean ± SD
20.0 ± 3.7
23.6 ± 4.3
< 0.001
VTE evaluation knowledge, mean ± SD
18.2 ± 4.0
23.4 ± 4.2
< 0.001
VTE prevention knowledge, mean ± SD
22.3 ± 3.4
25.4 ± 2.5
< 0.001
Total score, mean ± SD
62.4 ± 10.1
71.3 ± 11.4
< 0.001
Citation: Lu Y, Chen FY, Cai L, Huang CX, Shen XF, Cai LQ, Li XT, Fu YY, Wei J. Early warning prevention and control strategies to reduce perioperative venous thromboembolism in patients with gastrointestinal cancer. World J Clin Cases 2022; 10(10): 3035-3046